Bhatnagar Anish, Chief Executive Officer at SOLENO THERAPEUTICS INC (SLNO), sold 151,544 shares at $36.00 ($5.4M) on 2023-12-11, disclosed to the SEC on 2023-12-13.
Open-market sale of $5.4M SLNO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.26 | 51,205 | $1.8M | 33.5% |
| 2 | $35.26 | 51,205 | $1.8M | 33.5% |
| 3 | $36.00 | 35,272 | $1.3M | 23.5% |
| 4 | $37.01 | 6,931 | $257K | 4.8% |
| 5 | $37.01 | 6,931 | $257K | 4.8% |
| Total | $35.59 avg | 151,544 |
| $5.4M |
| 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $2.0M | — | Filing → |
| SLNO | SELL | 2024-08-30 | $10.9M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $11.6M | — | Filing → |